Centrally applied NPY mimics immunoactivation induced by non-analgesic doses of met-enkephalin

NeuroReport

Volumn 9, Issue 17, 1998, Pages 3881-3885

  Von Hörsten, Stephan ^a   Nave, Heike ^a   Ballof, Jan ^a   Helfritz, Fabian ^a   Meyer, Dirk ^a   Schmidt, Reinhold E ^a   Stalp, Michael ^a   Exton, Natalie G ^a   Exton, Michael S ^a   Straub, Rainer H ^b   Radulovic, Jelena ^c   Pabst, Reinhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Endogenous opioids; Granulocyte chemiluminescence; Hot plate test; Interleukin 6; Methionine enkephalin; Neuroimmunomodulation; Neuropeptide Y; NK cell cytotoxicity; Nociception; Stress

Indexed keywords

ANGIOTENSIN; METENKEPHALIN; NEUROPEPTIDE Y; OPIATE AGONIST; PHORBOL 13 ACETATE 12 MYRISTATE; ZYMOSAN;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; IMMUNE RESPONSE; IMMUNOMODULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NATURAL KILLER CELL; NOCICEPTION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT;

EID: 2542508916     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199812010-00021     Document Type: Article

References (25)

1. König M, Zimmer AM, Steiner H et al. Nature 383, 535-538 (1996).
2. Nerlich ML, Holch M, Stalp M et al. Trauma 37, 759-768 (1994).
3. Stefano GB, Salzet B, Fricchione GL. Immunol Today 19, 265-268 (1998).
4. Mellon RD and Bayer BM. J Neuroimmunol 83, 19-28 (1998).
5. Hsueh CM, Hiramoto RN, Ghanta VK. Brain Res 578, 142-148 (1992).
6. Radulovic J and Jankovic BD. Brain Res 661, 189-195 (1994).
7. Jankovic BD and Radulovic J. Int J Neurosci 67, 241-270 (1992).
8. Bertolucci M, Perego C and de Simoni MG. Am J Physiol 273, R956-R959 (1997).
9. Bodnar RJ. Crit Rev Neurobiol 6, 39-49 (1990).
10. Shavit J. Stress-induced immune modulation in animals: opiates and endogenous opioid peptides. In: Ader R, Felten DL and Cohen N, eds. Psychoneuroimmunology. San Diego: Academic Press, 1991: 789-804.
11. Wettstein JG, Earley B adn Junien JL. Pharmacol Ther 65, 397-414 (1995).
12. von Hörsten S, Ballof J, Helfritz F et al. Life Sci 63, 909-922 (1998).
13. von Hörsten S, Exton NG, Exton MS et al. Brain Res 806, 282-286 (1998)
14. Bileviciute I, Stenfors C, Theodorsson E et al. Brain Res 704, 71-78 (1995).
15. Broqua P, Wettstein JG, Rocher MN et al. Brain Res 724, 25-32 (1996).
16. Mellado ML, Gibert RJ, Chover AJ et al. Life Sci 58, 2409-2414 (1996).
17. Espejo EF and Mir D. Behav Brain Res 56, 171-176 (1993).
18. Ossipov MH, Kovelowski C, Nichols ML et al. Pain 62, 287-293 (1995).
19. von Hörsten S, Exton MS, Schult M et al. J Neuroimmunol 85, 193-201 (1998).
20. Millan MJ and Herz A. Int Rev Neurobiol 26, 1-83 (1985).
21. Noble F, Smadja C, Valverde O et al. Pain 73, 383-391 (1997).
22. Band LC, Pert A, Williams W et al. Prog Neurol Endocrinol Immunol 5, 95-101 (1992).
23. Straub RH, Herrmann M, Berkmiller G et al. J Neurochem 68, 1633-1639 (1997).
24. Bertolucci M, Perego C and de Simoni MG. NeuroReport 7, 1181-1184, (1996).
25. Shibasaki T, Tsumori C, Hotta M et al. Brain Res 688, 189-192 (1995).